Ophthalmic Therapeutics/Drug Market Report

Global and Region Ophthalmic Therapeutics/Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：165
  • REPORT CODE：GMM979271
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Ophthalmic Therapeutics/Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Ophthalmic Therapeutics/Drugmarket, defines the market attractiveness level of Ophthalmic Therapeutics/Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Ophthalmic Therapeutics/Drug industry, describes the types of Ophthalmic Therapeutics/Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ophthalmic Therapeutics/Drug market and the development prospects and opportunities of Ophthalmic Therapeutics/Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ophthalmic Therapeutics/Drug market in Chapter 13.

    By Player:

    • Genentech, Inc

    • Johnson and Johnson Vision Care, Inc

    • Alcon

    • Bayer AG

    • Pfizer Inc

    • Allergan

    • Novartis AG

    • Santen Pharmaceuticals Co Ltd

    • Merck Sharp & Dohme Corp

    • Regeneron Pharmaceuticals Inc

    • Valeant

    • Bausch & Lomb Incorporated

    By Type:

    • Anti-allergy

    • Anti-VEGF Agents

    • Anti-inflammatory

    • Anti-glaucoma

    • Others

    By End-User:

    • Dry Eye

    • Allergies

    • Glaucoma

    • Infection

    • Retinal Disorders

    • Uveitis

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Ophthalmic Therapeutics/Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Ophthalmic Therapeutics/Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Ophthalmic Therapeutics/Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Ophthalmic Therapeutics/Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Ophthalmic Therapeutics/Drug Market Analysis and Outlook to 2022

    • 7.1 Global Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    • 7.2 United States Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    • 7.3 Europe Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    • 7.4 China Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    • 7.5 Japan Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    • 7.6 India Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    • 7.7 South Korea Ophthalmic Therapeutics/Drug Consumption (2017-2022)

    8 Region and Country-wise Ophthalmic Therapeutics/Drug Market Analysis and Outlook to 2028

    • 8.1 Global Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    • 8.2 United States Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    • 8.4 China Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    • 8.6 India Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Ophthalmic Therapeutics/Drug Consumption Forecast (2022-2028)

    9 Global Ophthalmic Therapeutics/Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Ophthalmic Therapeutics/Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anti-allergy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Anti-VEGF Agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Anti-inflammatory Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Anti-glaucoma Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ophthalmic Therapeutics/Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Dry Eye Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Allergies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Glaucoma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Infection Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Retinal Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Uveitis Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Ophthalmic Therapeutics/Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Anti-allergy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Anti-VEGF Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Anti-inflammatory Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Anti-glaucoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Dry Eye Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Allergies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Retinal Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Uveitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Ophthalmic Therapeutics/Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Ophthalmic Therapeutics/Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Ophthalmic Therapeutics/Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Ophthalmic Therapeutics/Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Ophthalmic Therapeutics/Drug Market Competitive Analysis

    • 14.1 Genentech, Inc

      • 14.1.1 Genentech, Inc Company Details

      • 14.1.2 Genentech, Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Genentech, Inc Ophthalmic Therapeutics/Drug Product and Service

    • 14.2 Johnson and Johnson Vision Care, Inc

      • 14.2.1 Johnson and Johnson Vision Care, Inc Company Details

      • 14.2.2 Johnson and Johnson Vision Care, Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson and Johnson Vision Care, Inc Ophthalmic Therapeutics/Drug Product and Service

    • 14.3 Alcon

      • 14.3.1 Alcon Company Details

      • 14.3.2 Alcon Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Alcon Ophthalmic Therapeutics/Drug Product and Service

    • 14.4 Bayer AG

      • 14.4.1 Bayer AG Company Details

      • 14.4.2 Bayer AG Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bayer AG Ophthalmic Therapeutics/Drug Product and Service

    • 14.5 Pfizer Inc

      • 14.5.1 Pfizer Inc Company Details

      • 14.5.2 Pfizer Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Inc Ophthalmic Therapeutics/Drug Product and Service

    • 14.6 Allergan

      • 14.6.1 Allergan Company Details

      • 14.6.2 Allergan Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Allergan Ophthalmic Therapeutics/Drug Product and Service

    • 14.7 Novartis AG

      • 14.7.1 Novartis AG Company Details

      • 14.7.2 Novartis AG Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis AG Ophthalmic Therapeutics/Drug Product and Service

    • 14.8 Santen Pharmaceuticals Co Ltd

      • 14.8.1 Santen Pharmaceuticals Co Ltd Company Details

      • 14.8.2 Santen Pharmaceuticals Co Ltd Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Santen Pharmaceuticals Co Ltd Ophthalmic Therapeutics/Drug Product and Service

    • 14.9 Merck Sharp & Dohme Corp

      • 14.9.1 Merck Sharp & Dohme Corp Company Details

      • 14.9.2 Merck Sharp & Dohme Corp Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck Sharp & Dohme Corp Ophthalmic Therapeutics/Drug Product and Service

    • 14.10 Regeneron Pharmaceuticals Inc

      • 14.10.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.10.2 Regeneron Pharmaceuticals Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Regeneron Pharmaceuticals Inc Ophthalmic Therapeutics/Drug Product and Service

    • 14.11 Valeant

      • 14.11.1 Valeant Company Details

      • 14.11.2 Valeant Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Valeant Ophthalmic Therapeutics/Drug Product and Service

    • 14.12 Bausch & Lomb Incorporated

      • 14.12.1 Bausch & Lomb Incorporated Company Details

      • 14.12.2 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Ophthalmic Therapeutics/Drug

    • Figure Ophthalmic Therapeutics/Drug Picture

    • Table Global Ophthalmic Therapeutics/Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ophthalmic Therapeutics/Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ophthalmic Therapeutics/Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Ophthalmic Therapeutics/Drug Consumption by Country (2017-2022)

    • Figure United States Ophthalmic Therapeutics/Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Ophthalmic Therapeutics/Drug Consumption and Growth Rate (2017-2022)

    • Figure China Ophthalmic Therapeutics/Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Ophthalmic Therapeutics/Drug Consumption and Growth Rate (2017-2022)

    • Figure India Ophthalmic Therapeutics/Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ophthalmic Therapeutics/Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmic Therapeutics/Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ophthalmic Therapeutics/Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-allergy Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-VEGF Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-inflammatory Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-glaucoma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Dry Eye Consumption and Growth Rate (2017-2022)

    • Figure Global Allergies Consumption and Growth Rate (2017-2022)

    • Figure Global Glaucoma Consumption and Growth Rate (2017-2022)

    • Figure Global Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Retinal Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Uveitis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-allergy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-VEGF Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-inflammatory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-glaucoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dry Eye Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Allergies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retinal Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Uveitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Ophthalmic Therapeutics/Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Ophthalmic Therapeutics/Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Genentech, Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc Ophthalmic Therapeutics/Drug Product and Service

    • Table Johnson and Johnson Vision Care, Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Vision Care, Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Vision Care, Inc Ophthalmic Therapeutics/Drug Product and Service

    • Table Alcon (Foundation Year, Company Profile and etc.)

    • Table Alcon Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alcon Ophthalmic Therapeutics/Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Ophthalmic Therapeutics/Drug Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Ophthalmic Therapeutics/Drug Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Ophthalmic Therapeutics/Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Ophthalmic Therapeutics/Drug Product and Service

    • Table Santen Pharmaceuticals Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Santen Pharmaceuticals Co Ltd Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Santen Pharmaceuticals Co Ltd Ophthalmic Therapeutics/Drug Product and Service

    • Table Merck Sharp & Dohme Corp (Foundation Year, Company Profile and etc.)

    • Table Merck Sharp & Dohme Corp Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Corp Ophthalmic Therapeutics/Drug Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Ophthalmic Therapeutics/Drug Product and Service

    • Table Valeant (Foundation Year, Company Profile and etc.)

    • Table Valeant Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Ophthalmic Therapeutics/Drug Product and Service

    • Table Bausch & Lomb Incorporated (Foundation Year, Company Profile and etc.)

    • Table Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US